RGC Stock: Price, Forecast, Financials & AI Analysis

Loading...

Loading chart...

High

26.875

Open

26.250

VWAP

25.30

Vol

114.75K

Mkt Cap

12.12B

Low

24.500

Amount

2.90M

EV/EBITDA(TTM)

--

Total Shares

494.49M

EV

12.80B

EV/OCF(TTM)

--

P/S(TTM)

--

Regencell Bioscience Holdings Ltd is a bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The Company launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.

Show More

Events Timeline

(ET)

2026-03-09

11:10:00

Regencell Bioscience Holdings Ltd Trading Halted

2026-03-09

10:10:00

Regencell Bioscience Shares Down 7.9% to $21.50

2026-02-13 (ET)

2026-02-13

10:10:00

Regencell Bioscience Stock Rises 18.2% to $34.30

2026-02-03 (ET)

2026-02-03

08:50:00

Regencell Borrow Rate Increases to 192.53%

2026-02-02 (ET)

2026-02-02

10:10:00

Regencell Bioscience Shares Rise 11.6% to $27.89

2026-02-02

08:50:00

Borrow Rates Rise for Direxion LABU to 7.93%

2026-01-27 (ET)

2026-01-27

10:10:00

Regencell Bioscience Stock Rises 15.4% to $33.69

2026-01-26 (ET)

2026-01-26

10:10:00

Regencell Bioscience Shares Down 10.9% to $28.00

News

Barron's

S&P 500 Futures Hold Steady in Pre-Market Session; Vertex Pharmaceuticals and UFP Industries Take the Lead

Fool

Regencell Bioscience Market Risk Analysis

NASDAQ.COM

03-07NASDAQ.COM

Regencell Bioscience Faces High-Risk Investment Landscape

Yahoo Finance

03-07Yahoo Finance

Regencell Bioscience Investment Warning

Fool

Regencell Bioscience: A High-Risk Investment in TCM

NASDAQ.COM

03-05NASDAQ.COM

Investment Analysis of Regencell Bioscience's Risks

Valuation Metrics

The current forward P/E ratio for Regencell Bioscience Holdings Ltd (RGC.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Regencell Bioscience Holdings Ltd's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

dotted line Image

N/A

5Y Average PE

0.00

Current PE

0.00

Overvalued PE

0.00

Undervalued PE

0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

dotted line Image

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

dotted line Image

N/A

5Y Average PS

0.00

Current PS

0.00

Overvalued PS

0.00

Undervalued PS

0.00

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

bullish stocks this week

Intellectia · 56 candidates

Market Cap: >= 4.00BRegion: USList Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20Week Price Change Pct: >= $10.00Monthly Average Dollar Volume: >= 1,000,000

Ticker

Name

Market Cap$

Masimo Corp

9.43B

Immunitybio Inc

8.41B

Ondas Inc

4.98B

Moderna Inc

18.21B

elf Beauty Inc

5.20B

Kratos Defense and Security Solutions Inc

17.84B

ابي سهم التارقت حقي يكون اجيب فوق 25% واعلى من راس مالي

Intellectia · 1346 candidates

Year Price Change Pct: >= $25.00

Ticker

Name

Market Cap$

Regencell Bioscience Holdings Ltd

13.54B

Palatin Technologies Inc

28.78M

Rich Sparkle Holdings Ltd

875.38M

Abivax SA

8.86B

Sandisk Corp

97.55B

Hycroft Mining Holding Corporation

3.20B

what’s a good buy for day trading

Intellectia · 2418 candidates

Region: USPrice: $2.00 - $200.00Volume: >= 200,000List Exchange: XNYS, XNAS, XASE

Ticker

Name

Market Cap$

AstraZeneca PLC

298.35B

Planet Green Holdings Corp

30.35M

Aquestive Therapeutics Inc

509.36M

Perspective Therapeutics Inc

351.47M

Ascent Solar Technologies Inc

29.36M

PAVmed Inc

9.16M

entonces que acciones?

Intellectia · 74 candidates

Market Cap: >= 3.00BRsi Category: moderateWeek Price Change Pct: $5.00 - $20.00Ema 20: >= -100Ema 60: >= -100Monthly Average Dollar Volume: >= 1,000,000

Ticker

Name

Market Cap$

Sasol Ltd

4.76B

Lemonade Inc

6.97B

Telecom Argentina SA

5.50B

Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP

18.55B

Korea Electric Power Corp

27.73B

Posco Holdings Inc

19.18B

Intellectia · 2866 candidates

Pe Ttm: <= 10

Ticker

Name

Market Cap$

SL Green Realty Corp

3.35B

Avadel Pharmaceuticals PLC

2.11B

HubSpot Inc

15.84B

Arrowhead Pharmaceuticals Inc

9.42B

PDF Solutions Inc

1.42B

Trivago NV

197.86M

what stocks is up more than 500%

Intellectia · 22 candidates

Weekly Average Turnover: >= 1,000,000Year Price Change Pct: >= $500.00

Ticker

Name

Market Cap$

Sandisk Corp

73.47B

Regencell Bioscience Holdings Ltd

10.83B

Abivax SA

9.41B

Celcuity Inc

4.96B

Terns Pharmaceuticals Inc

3.99B

Hycroft Mining Holding Corporation

3.22B

Whales Holding RGC

Trading Trends

People Also Watch

Frequently Asked Questions

What is Regencell Bioscience Holdings Ltd (RGC) stock price today?

The current price of RGC is 24.51 USD — it has decreased -5.37

What is Regencell Bioscience Holdings Ltd (RGC)'s business?

Regencell Bioscience Holdings Ltd is a bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The Company launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.

What is the price predicton of RGC Stock?

Wall Street analysts forecast RGC stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for RGC is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Regencell Bioscience Holdings Ltd (RGC)'s revenue for the last quarter?

Regencell Bioscience Holdings Ltd revenue for the last quarter amounts to NaN USD, decreased

What is Regencell Bioscience Holdings Ltd (RGC)'s earnings per share (EPS) for the last quarter?

Regencell Bioscience Holdings Ltd. EPS for the last quarter amounts to USD, decreased

How many employees does Regencell Bioscience Holdings Ltd (RGC). have?

Regencell Bioscience Holdings Ltd (RGC) has 12 emplpoyees as of March 11 2026.

What is Regencell Bioscience Holdings Ltd (RGC) market cap?

Today RGC has the market capitalization of 12.12B USD.